Nordic Life Science Awards

Get the presentations from the selected finalists and applause the winners

Nordic Life Science Awards

16:30 - 19:00 NLSDays Arena - Exhibition Hall

This year we inaugurate the new Nordic Life Science Awards competition, opened to two participants categories, academia and start-up companies.

Part 1 – Nordic Life Science Academia Award

The Nordic Life Science Award for Academia features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivations to advance their ideas into innovations for patients. The session is hosted by SPARK Norway and delivered in collaboration with SPARK Finland, SciLifeLab Sweden and the Danish BioInnovation Institute.

Academia is a key engine for medical innovation and many life science projects becoming commercial successful originate from academic centers. Big ideas very often come from ground-braking academic research. Recognizing that the majority of the global companies made academic-industrial partnerships an integral part of their strategies and opened their R&D organizations to external innovation.

 SciLifeLab Sweden 

  • “Improving the drugability of neoantigens in immuno-oncology”, Sara Mangsbo, Uppsala University 
  • “MTHFD2 as new DDR strategy for targeting cancer by synthetic lethality”, Thomas Helleday, Karolinska Institute 
 SPARK Norway, UiO:Life Science at the University of Oslo 

  • “A biologic therapeutic for pulmonary fibrosis”, Ole Jørgen Kaasbøll, University of Oslo, SPARK Norway 
  • “Novel treatment for heart failure”, Maria Vistnes, Univ. of Oslo / SPARK Norway (tbc) 
 SPARK Finland 

  • “Nextcast, AI solution for chemical and drug toxicity testing”, Troy Faithfull, SPARK Finland 
  • “A novel Parkinson’s signature biomarker assay”, Patrik Hollos, SPARK Finland 
 BioInnovation Institute Denmark 

  • “A new drug for treatment-resistant depression”, Emil Märcher-Rørsted, University of Copenhagen 
  • “Novel detoxification technology turning bacterial toxins into vaccines antigens”; Kaper Gubba Ørtenblad, Statens Serum Institute 
 Iceland 

  • ”Placental protein 13 used to prevent preeclampsia”, Sveinbjörn Gizurarson, University of Iceland 

Hosted by:

Spark Norway

Spark Norway

Spark Finland

Spark Finland

SciLifeLab

SciLifeLab

BioInnovation Institute

BioInnovation Institute

UiO: University of Oslo

UiO: University of Oslo

Sponsored by:

EIT Health Scandinavia

EIT Health Scandinavia

full program